Semaglutide can increase the risk of hypoglycemia, especially when starting treatment or adjusting the dose
According to the data provided by the Synapse Database, As of March 29 2024, there are 46 investigational drugs for the GIPR and GLP-1R target, including 30 indications, 39 R&D institutions involved, with related clinical trials reaching 185, and as many as 1416 patents
Pre-protocol baseline and follow-up testing are essential
Ozempic was originally developed and approved solely for type 2 diabetes management
The connection between ADHD and GLP1 hormones is still emerging, but it points to something many women with ADHD have known for a long time: ADHD is not just all in your head. Your brain does not operate in isolation from the rest of your body
Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy